Neurodegenerative Disease

LAUSANNE, Switzerland, August 11, 2026 AC Immune SA announced that the U.S. Food and Drug Administration (FDA) has granted...

New York, New York, August,11, 2026 Graviton Bioscience Corporation, a clinical-stage biotechnology company developing selective ROCK2 inhibitors, has announced...

SALT LAKE CITY, Utah, August 10, 2026 Clene Inc. announced new biomarker analyses for CNM-Au8 that will be included...

MECHELEN, Belgium, August 10, 2026 Lakefront Biotherapeutics NV reported its half-year 2026 financial results and provided a business update...

FREMONT, California, August 10, 2026 Alamar Biosciences, Inc. announced an expansion of its strategic partnership with the Alzheimer’s Disease...

CARSON CITY, Nev., August 6, 2026 BioVie Inc. announced positive topline results from its Phase 2 SUNRISE-PD trial, demonstrating...

Sacramento & San Diego, California, August 4, 2026 Lunai Bioworks Inc. has announced a definitive Master Collaboration Agreement with...

BOSTON, July 31, 2026 Tiziana Life Sciences announced new quantitative PET imaging results from the third patient with Multiple...

JACKSONVILLE, Fla., July 30, 2026 Medical Microinstruments (MMI) announced that the U.S. Food and Drug Administration (FDA) has approved...

BOSTON, TOKYO and SUZHOU, July 28, 2026 CORE Biomedicine, a biotechnology company advancing lineage-based precision oncology therapeutics, has announced...